Sinovac Biotech R&D Spending Growth & History (SVA)

Sinovac Biotech's r&d spending was $216.2M for fiscal 2025.

View full Sinovac Biotech company overview

Sinovac Biotech annual r&d spending history

Sinovac Biotech annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$216.2M−$54.5M−20.13%
20242024-12-31$270.7M−$79.5M−22.71%
20232023-12-31$350.2M−$128.5M−26.84%
20222022-12-31$478.7M$326.0M+213.49%
20212021-12-31$152.7M$103.9M+213.16%
20202020-12-31$48.8M$24.5M+101.04%
20192019-12-31$24.3M$2.3M+10.70%
20182018-12-31$21.9M$1.4M+6.94%
20172017-12-31$20.5M$7.8M+61.99%
20162016-12-31$12.6M$3.2M+33.28%
20152015-12-31$9.5M−$1.4M−13.21%
20142014-12-31$10.9M$2.8M+34.52%
20132013-12-31$8.1M−$8.9M−52.31%
20122012-12-31$17.0M$8.0M+89.23%
20112011-12-31$9.0M$499,204+5.87%
20102010-12-31$8.5M$4.1M+93.11%
20092009-12-31$4.4M

Sinovac Biotech r&d spending trends

Over the last five fiscal years, Sinovac Biotech's r&d spending increased from $48.8M to $216.2M, a change of $167.4M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sinovac Biotech source filings ↗

Community posts

It’s quiet here.

No posts about SVA yet. Start the conversation.

Write the first post